Product Information
INT-767 is a drug that inhibits the activity of toll-like receptor 4 (TLR4). It has been shown to inhibit the synthesis of collagen, which is an important component of fibrosis. INT-767 also counteracts some pharmacological treatments used in the treatment of metabolic disorders, such as diabetes and obesity. This drug selectively blocks TLR4 signaling pathways involved in inflammation, thereby inhibiting the production of cytokines and chemokines. INT-767 has been shown to reduce hepatic steatosis by reducing fat accumulation and decreasing levels of fatty acids in liver cells. In vitro studies have shown that INT-767 reduces cell proliferation and induces apoptosis by increasing expression of proteins involved in this process.
Chemical properties
Technical inquiry about: 3D-AQB40303 INT-767
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
